Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
BioSig Technologies Announces New Collaboration on Development of Artificial Intelligence Solutions in Healthcare | ||
By: GlobeNewswire - 03 Dec 2019 | Back to overview list |
|
Westport, CT, Dec. 03, 2019 (GLOBE NEWSWIRE) -- ·The Company partners with Reified Capital, a provider of advanced artificial intelligence-focused technical advisory services to the private sector ·Collaboration to focus on machine learning and artificial intelligence solutions for healthcare ·Initial solutions to be centered on BioSig’s core competencies in electrophysiology BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company developing a proprietary biomedical signal processing platform designed to improve signal fidelity and uncover the full range of ECG and intra-cardiac signals, today announced that the Company entered into a technical collaboration with Reified Capital, a provider of advanced artificial intelligence-focused technical advisory services to the private sector. Reified was co-founded by Dr. Alexander D. Wissner-Gross and Timothy M. Sullivan, the founders of Gemedy. The new collaboration with Cambridge, Massachusetts-based Reified will focus on developing a foundational artificial intelligence platform on the basis of integrated healthcare datasets, beginning with ECG and EEG data acquired by BioSig’s first product, PURE EP(tm) System - a novel real-time signal processing platform engineered to provide electrophysiologists with high fidelity cardiac signals. Electrophysiology focused technological solutions developed under the terms of this collaboration will be integrated into the PURE EP(tm) technology platform. Reified is led by Harvard- and MIT-trained computer scientist and physicist Dr. Wissner-Gross, an award-winning computer scientist, physicist, entrepreneur and author. Technical expertise that the Reified team is planning to bring to the project includes data analysis, algorithmic modeling and development. “Integration of AI can open new avenues for improved diagnosis and more effective therapy delivery for bioelectronic medicine in particular and healthcare in general. We are thrilled to partner with Alex and his outstanding team, and look forward to working with them on developing world-class artificial intelligence and machine learning solutions, which, we believe, will benefit a worldwide physician audience,” commented Kenneth L Londoner, Chairman and CEO of BioSig Technologies, Inc. “The application of modern AI and machine learning techniques to electrophysiology presents one of the most promising healthcare opportunities of our time,” said Dr. Wissner-Gross. “We look forward to our forthcoming collaboration with BioSig Technologies.” About Reified Capital About BioSig Technologies Forward-looking Statements
CONTACT: Contact: Andrew Ballou BioSig Technologies, Inc. Vice President, Investor Relations 54 Wilton Road, 2nd floor Westport, CT 06880 aballou@biosigtech.com 203-409-5444, x119 |
||
|
||
Copyright 2019 GlobeNewswire | Back to overview list |